Methyl candesartan (CAS No: 139481-69-9) is a key pharmaceutical intermediate used in the synthesis of APIs Candesartan and Candesartan cilexetil. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: Candesartan cilexetil impurity I [EP], Methyl 1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-ethoxybenzimidazole-7-carboxylate
CAS No: 139481-69-9
PubChem CID: 15654696
Mol Formula: C25H22N6O3
Mol Weight: 454.5 g/mol
Used in APIs: Candesartan and Candesartan cilexetil
IUPAC Name: methyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate
API Intermediate Description: Methyl candesartan is a pharmaceutical intermediate used in the synthesis of the active pharmaceutical ingredient candesartan or its prodrug candesartan cilexetil. While it contains the core candesartan structure, it requires further chemical transformations to produce the final drug used in hypertension and heart failure therapy.
